Human & Veterinary Medicine

Human & Veterinary Medicine

You are here › Home · Volume 9(4)/2017

Volume 9(4)/2017

First pages 2017;9(4):i-vi.

Catinean A, Neag MA, Pop D. Different presentations of gastroesophageal reflux disease. HVM Bioflux 2017;9(4):111-115.

Groza I, Acalovschi M, Pasca S, Andreica V, Tantau M, Matei D. Factors predictive of relapse in variceal upper gastrointestinal bleeding. A prospective study in patients with liver cirrhosis. HVM Bioflux 2017;9(4):116-123.

Marginean C, Procopciuc L, Fodoreanu L. Implications of MTHFR polymorphisms in the development of treatment-resistant schizophrenia. HVM Bioflux 2017;9(4):124-129.

Tomina D, Roman A, Condor D, Dinu C, Petruțiu SA. Experimental rat model – is it still used? – review article. HVM Bioflux 2017;9(4):130-136.

Benaissa MH, Mimoune N, Kaidi R. Prevalence and anatomohistopathologic studies of uterine anomalies in she-camels in southeast Algeria. HVM Bioflux 2017;9(4):137-145.

Bolba IM, Dina LA, Badea RI, Rusu I, Ciobanu L, Vasile T. Moderately differentiated neuroendocrine tumor (NET G2) of the pancreatic tail - stage IV clinical case. HVM Bioflux 2017;9(4):146-151.

Mois E, Graur F, Al Hajjar M, Puia C, Zaharie F, Pop F, Furcea L, Zeama C, Radu C, Bartos A, Iancu C. Factors determining microscopic positive resection margins after gastrectomy for gastric adenocarcinoma. HVM Bioflux 2017;9(4):152-156.

Milaciu MV, Ciumarnean L, Sampelean DP, Bocsan IC, Popa DE, Pasca S, Acalovschi M. Paraoxonase 1 activities and gene polymorphisms in non-alcoholic steatohepatitis – preliminary results of a pilot study. HVM Bioflux 2017;9(4):157-160.

Stoian A, Balasa R, Barcutean L, Motataianu A, Mocan S, Maier S, Bajko S, Szasz S. An unusual cause of longitudinally extensive transverse myelitis - case report. HVM Bioflux 2017;9(4):161-165.

Dumitru C, Bastian A, Popp C, Neagu M, Constantin C, Cioplea M, Nichita L, Andrei R, Vassu T, Zurac S. Immunohistochemical features of partial regression in cutaneous melanoma – E-cadherin key molecule. HVM Bioflux 2017;9(4):166-177.

Apan B, Cristina A, Bala CG, Morariu D, Macarie AE, Crisan A, Ilia T, Bocsan CI, Buzoianu AD. Evolution of anthropometric and biochemical parameters after 6 months of treatment with exenatide compared to dapagliflozin in patients with type 2 diabetes. HVM Bioflux 2017;9(4):178-182.

10.06.2017. 09:29